- Report
- October 2023
- 188 Pages
Global
From €3959EUR$4,500USD£3,435GBP
- Report
- October 2023
- 137 Pages
Asia Pacific
From €3519EUR$4,000USD£3,053GBP
- Report
- October 2023
- 178 Pages
Global
From €3959EUR$4,500USD£3,435GBP
- Report
- September 2023
- 175 Pages
Global
From €3959EUR$4,500USD£3,435GBP
- Report
- August 2024
- 82 Pages
Japan
From €3079EUR$3,500USD£2,672GBP
- Report
- July 2024
- 190 Pages
Global
From €3959EUR$4,500USD£3,435GBP
- Report
- June 2024
- 84 Pages
United Kingdom
From €3079EUR$3,500USD£2,672GBP
- Report
- October 2023
- 182 Pages
Global
From €3959EUR$4,500USD£3,435GBP
- Report
- August 2023
- 76 Pages
Israel
From €3079EUR$3,500USD£2,672GBP
- Report
- July 2024
- 153 Pages
Global
From €3178EUR$3,613USD£2,757GBP
€3739EUR$4,250USD£3,244GBP
- Report
- June 2025
- 250 Pages
Canada
From €2453EUR$2,789USD£2,129GBP
- Report
- June 2025
- 250 Pages
France
From €2453EUR$2,789USD£2,129GBP
- Report
- September 2024
- 150 Pages
Global
From €3387EUR$3,850USD£2,939GBP
€4267EUR$4,850USD£3,702GBP
- Report
- May 2025
- 115 Pages
Australia
From €3166EUR$3,599USD£2,747GBP
- Report
- June 2023
- 73 Pages
Africa, Middle East
From €1320EUR$1,500USD£1,145GBP
- Report
- January 2023
- 209 Pages
Global
From €3167EUR$3,600USD£2,748GBP
- Report
- January 2023
- 74 Pages
North America
From €1320EUR$1,500USD£1,145GBP
- Report
- January 2023
- 83 Pages
Middle East, Africa
From €1320EUR$1,500USD£1,145GBP
- Report
- January 2023
- 83 Pages
Europe
From €1320EUR$1,500USD£1,145GBP
- Report
- January 2023
- 84 Pages
Asia Pacific
From €1320EUR$1,500USD£1,145GBP

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more